Patients with chronic hepatitis B in Asia exposed to inadequate treatment
Published: 2003-10-23 06:59:00
Updated: 2003-10-23 06:59:00
The majority of patients suffering from chronic hepatitis B (CHB) in Asian countries have yet to receive adequate antiviral treatment in an earlier stage unlike those patients suffering from hypertension, diabetes and tuberculosis, according to a healthcare market research agency.
In its surve...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
